Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 476 entries
Sorted by: Best Match Show Resources per page
Surveying the influence of laboratory information system: an end-user perspective

community settings

Alanazi A, Aldosari B, Househ M.
GSID: uvXmBIVmFJEJ
B Aldosari, HA Gadi, A Alanazi, M Househ - Informatics in Medicine …, 2017 - Elsevier

Background The goal of the present survey is to investigate the effect of the Laboratory Information System (LIS) among users in a tertiary healthcare facility in Saudi Arabia …

Cite
Aldosari, B., Gadi, H. A., Alanazi, A., & Househ, M. (2017). Surveying the influence of laboratory information system: an end-user perspective. Informatics in Medicine Unlocked, 9, 200-209.
Aldosari, Bakheet, et al. "Surveying the influence of laboratory information system: an end-user perspective." Informatics in Medicine Unlocked 9 (2017): 200-209.
Copy Download .nbib Format: MLA
Infections Caused by Stenotrophomonas maltophilia in Recipients of Hematopoietic Stem Cell Transplantation.

Frontiers in oncology

Al-Anazi KA, Al-Jasser AM.
PMID: 25202682
Front Oncol. 2014 Aug 25;4:232. doi: 10.3389/fonc.2014.00232. eCollection 2014.

Stenotrophomonas maltophilia (S. maltophilia) is a globally emerging Gram-negative bacillus that is widely spread in environment and hospital equipment. Recently, the incidence of infections caused by this organism has increased, particularly in patients with hematological malignancy and in recipients...

Cite
Al-Anazi KA, Al-Jasser AM. Infections Caused by Stenotrophomonas maltophilia in Recipients of Hematopoietic Stem Cell Transplantation. Front Oncol. 2014;4:232doi: 10.3389/fonc.2014.00232.
Al-Anazi, K. A., & Al-Jasser, A. M. (2014). Infections Caused by Stenotrophomonas maltophilia in Recipients of Hematopoietic Stem Cell Transplantation. Frontiers in oncology, 4232. https://doi.org/10.3389/fonc.2014.00232
Al-Anazi, Khalid Ahmed, and Al-Jasser, Asma M. "Infections Caused by Stenotrophomonas maltophilia in Recipients of Hematopoietic Stem Cell Transplantation." Frontiers in oncology vol. 4 (2014): 232. doi: https://doi.org/10.3389/fonc.2014.00232
Al-Anazi KA, Al-Jasser AM. Infections Caused by Stenotrophomonas maltophilia in Recipients of Hematopoietic Stem Cell Transplantation. Front Oncol. 2014 Aug 25;4:232. doi: 10.3389/fonc.2014.00232. eCollection 2014. PMID: 25202682; PMCID: PMC4142553.
Copy Download .nbib Format: NLM
Biopharmaceutical applications of nanogold.

Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society

Alanazi FK, Radwan AA, Alsarra IA.
PMID: 24936133
Saudi Pharm J. 2010 Oct;18(4):179-93. doi: 10.1016/j.jsps.2010.07.002. Epub 2010 Jul 24.

The application of nanogold in biopharmaceutical field is reviewed in this work. The properties of nanogold including nanogold surface Plasmon absorption and nanogold surface Plasmon light scattering are illustrated. The physical, chemical, biosynthesis methods of nanogold preparation are presented....

Cite
Alanazi FK, Radwan AA, Alsarra IA. Biopharmaceutical applications of nanogold. Saudi Pharm J. 2010;18(4):179-93doi: 10.1016/j.jsps.2010.07.002.
Alanazi, F. K., Radwan, A. A., & Alsarra, I. A. (2010). Biopharmaceutical applications of nanogold. Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society, 18(4), 179-93. https://doi.org/10.1016/j.jsps.2010.07.002
Alanazi, Fars K, et al. "Biopharmaceutical applications of nanogold." Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society vol. 18,4 (2010): 179-93. doi: https://doi.org/10.1016/j.jsps.2010.07.002
Alanazi FK, Radwan AA, Alsarra IA. Biopharmaceutical applications of nanogold. Saudi Pharm J. 2010 Oct;18(4):179-93. doi: 10.1016/j.jsps.2010.07.002. Epub 2010 Jul 24. PMID: 24936133; PMCID: PMC4052511.
Copy Download .nbib Format: NLM
Relation between glycosylated hemoglobin and lipid and thyroid hormone among patients with type 2 diabetes mellitus at King Abdulaziz Medical City, Riyadh.

Journal of natural science, biology, and medicine

Karar T, Alhammad RI, Fattah MA, Alanazi A, Qureshi S.
PMID: 26604625
J Nat Sci Biol Med. 2015 Aug;6:S75-9. doi: 10.4103/0976-9668.166091.

BACKGROUND: The main objectives of this study were to: (1) Evaluate the levels of thyroid hormones and glycosylated hemoglobin (HbA1c) among patients, (2) correlate between thyroid hormones and HbA1c and different types of lipids and HbA1c among diabetic patients.MATERIALS...

Cite
Karar T, Alhammad RI, Fattah MA, et al. Relation between glycosylated hemoglobin and lipid and thyroid hormone among patients with type 2 diabetes mellitus at King Abdulaziz Medical City, Riyadh. J Nat Sci Biol Med. 2015;6:S75-9doi: 10.4103/0976-9668.166091.
Karar, T., Alhammad, R. I., Fattah, M. A., Alanazi, A., & Qureshi, S. (2015). Relation between glycosylated hemoglobin and lipid and thyroid hormone among patients with type 2 diabetes mellitus at King Abdulaziz Medical City, Riyadh. Journal of natural science, biology, and medicine, 6S75-9. https://doi.org/10.4103/0976-9668.166091
Karar, Tarig, et al. "Relation between glycosylated hemoglobin and lipid and thyroid hormone among patients with type 2 diabetes mellitus at King Abdulaziz Medical City, Riyadh." Journal of natural science, biology, and medicine vol. 6 (2015): S75-9. doi: https://doi.org/10.4103/0976-9668.166091
Karar T, Alhammad RI, Fattah MA, Alanazi A, Qureshi S. Relation between glycosylated hemoglobin and lipid and thyroid hormone among patients with type 2 diabetes mellitus at King Abdulaziz Medical City, Riyadh. J Nat Sci Biol Med. 2015 Aug;6:S75-9. doi: 10.4103/0976-9668.166091. PMID: 26604625; PMCID: PMC4630769.
Copy Download .nbib Format: NLM
Pravastatin chitosan nanogels-loaded erythrocytes as a new delivery strategy for targeting liver cancer.

Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society

Harisa GI, Badran MM, AlQahtani SA, Alanazi FK, Attia SM.
PMID: 26903771
Saudi Pharm J. 2016 Jan;24(1):74-81. doi: 10.1016/j.jsps.2015.03.024. Epub 2015 Mar 21.

Chitosan nanogels (CNG) are developed as one of the most promising carriers for cancer targeting. However, these carriers are rapidly eliminated from circulation by reticuloendothelial system (RES), which limits their application. Therefore, erythrocytes (ER) loaded CNG as multifunctional carrier...

Cite
Harisa GI, Badran MM, AlQahtani SA, et al. Pravastatin chitosan nanogels-loaded erythrocytes as a new delivery strategy for targeting liver cancer. Saudi Pharm J. 2015;24(1):74-81doi: 10.1016/j.jsps.2015.03.024.
Harisa, G. I., Badran, M. M., AlQahtani, S. A., Alanazi, F. K., & Attia, S. M. (2016). Pravastatin chitosan nanogels-loaded erythrocytes as a new delivery strategy for targeting liver cancer. Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society, 24(1), 74-81. https://doi.org/10.1016/j.jsps.2015.03.024
Harisa, Gamaleldin I, et al. "Pravastatin chitosan nanogels-loaded erythrocytes as a new delivery strategy for targeting liver cancer." Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society vol. 24,1 (2016): 74-81. doi: https://doi.org/10.1016/j.jsps.2015.03.024
Harisa GI, Badran MM, AlQahtani SA, Alanazi FK, Attia SM. Pravastatin chitosan nanogels-loaded erythrocytes as a new delivery strategy for targeting liver cancer. Saudi Pharm J. 2016 Jan;24(1):74-81. doi: 10.1016/j.jsps.2015.03.024. Epub 2015 Mar 21. PMID: 26903771; PMCID: PMC4720020.
Copy Download .nbib Format: NLM
Impact of lipid disorders on mortality among Saudi patients with heart failure.

Journal of the Saudi Heart Association

Al Qahtani M, Al Backer T, Al Anazi T, Al Johani N, Binsalih S, AlGobain M, Alshammari H.
PMID: 25870502
J Saudi Heart Assoc. 2015 Apr;27(2):91-5. doi: 10.1016/j.jsha.2014.12.003. Epub 2014 Dec 23.

BACKGROUND: Dyslipidemia, a known cardiovascular risk factor, is extremely common among Saudis, both adults and children. The impact, however, of dyslipidemia and several other lipid disorders in patients with congestive heart failure in this particular population has not been...

Cite
Al Qahtani M, Al Backer T, Al Anazi T, et al. Impact of lipid disorders on mortality among Saudi patients with heart failure. J Saudi Heart Assoc. 2014;27(2):91-5doi: 10.1016/j.jsha.2014.12.003.
Al Qahtani, M., Al Backer, T., Al Anazi, T., Al Johani, N., Binsalih, S., AlGobain, M., & Alshammari, H. (2015). Impact of lipid disorders on mortality among Saudi patients with heart failure. Journal of the Saudi Heart Association, 27(2), 91-5. https://doi.org/10.1016/j.jsha.2014.12.003
Al Qahtani, M, et al. "Impact of lipid disorders on mortality among Saudi patients with heart failure." Journal of the Saudi Heart Association vol. 27,2 (2015): 91-5. doi: https://doi.org/10.1016/j.jsha.2014.12.003
Al Qahtani M, Al Backer T, Al Anazi T, Al Johani N, Binsalih S, AlGobain M, Alshammari H. Impact of lipid disorders on mortality among Saudi patients with heart failure. J Saudi Heart Assoc. 2015 Apr;27(2):91-5. doi: 10.1016/j.jsha.2014.12.003. Epub 2014 Dec 23. PMID: 25870502; PMCID: PMC4392377.
Copy Download .nbib Format: NLM
The beneficial roles of Lupineus luteus and lifestyle changes in management of metabolic syndrome: A case study.

Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society

Harisa GI, Alanazi FK.
PMID: 26702267
Saudi Pharm J. 2015 Nov;23(6):712-5. doi: 10.1016/j.jsps.2015.02.006. Epub 2015 Feb 27.

Metabolic syndrome (MetS) is a cluster of cardiovascular risk factors including obesity, hypertension, dyslipidemia and hyperuricemia. Here, we report a 43-year-old man with obesity, hypertension, hypercholesterolemia, hyperuricemia and mild liver dysfunctions. Lupid (Lupineus luteus) and therapeutic lifestyle change (TLC)...

Cite
Harisa GI, Alanazi FK. The beneficial roles of Lupineus luteus and lifestyle changes in management of metabolic syndrome: A case study. Saudi Pharm J. 2015;23(6):712-5doi: 10.1016/j.jsps.2015.02.006.
Harisa, G. I., & Alanazi, F. K. (2015). The beneficial roles of Lupineus luteus and lifestyle changes in management of metabolic syndrome: A case study. Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society, 23(6), 712-5. https://doi.org/10.1016/j.jsps.2015.02.006
Harisa, Gamaleldin I, and Alanazi, Fars K. "The beneficial roles of Lupineus luteus and lifestyle changes in management of metabolic syndrome: A case study." Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society vol. 23,6 (2015): 712-5. doi: https://doi.org/10.1016/j.jsps.2015.02.006
Harisa GI, Alanazi FK. The beneficial roles of Lupineus luteus and lifestyle changes in management of metabolic syndrome: A case study. Saudi Pharm J. 2015 Nov;23(6):712-5. doi: 10.1016/j.jsps.2015.02.006. Epub 2015 Feb 27. PMID: 26702267; PMCID: PMC4669417.
Copy Download .nbib Format: NLM
Acinetobacter baumannii Septicemia in a Recipient of an Allogeneic Hematopoietic Stem Cell Transplantation.

Case reports in transplantation

Al-Anazi KA, Abdalhamid B, Alshibani Z, Awad K, Alzayed A, Hassan H, Alsayiegh M.
PMID: 23259136
Case Rep Transplant. 2012;2012:646195. doi: 10.1155/2012/646195. Epub 2012 Aug 07.

Acinetobacter baumannii is a gram-negative, nonfermentative coccobacillus that causes infections in immunocompromised and chronically ill patients and is associated with multidrug resistance. Two days before receiving her nonmyeloablative stem cell allograft, a patient with acute myeloid leukemia developed Acinetobacter...

Cite
Al-Anazi KA, Abdalhamid B, Alshibani Z, et al. Acinetobacter baumannii Septicemia in a Recipient of an Allogeneic Hematopoietic Stem Cell Transplantation. Case Rep Transplant. 2012;2012:646195doi: 10.1155/2012/646195.
Al-Anazi, K. A., Abdalhamid, B., Alshibani, Z., Awad, K., Alzayed, A., Hassan, H., & Alsayiegh, M. (2012). Acinetobacter baumannii Septicemia in a Recipient of an Allogeneic Hematopoietic Stem Cell Transplantation. Case reports in transplantation, 2012646195. https://doi.org/10.1155/2012/646195
Al-Anazi, Khalid Ahmed, et al. "Acinetobacter baumannii Septicemia in a Recipient of an Allogeneic Hematopoietic Stem Cell Transplantation." Case reports in transplantation vol. 2012 (2012): 646195. doi: https://doi.org/10.1155/2012/646195
Al-Anazi KA, Abdalhamid B, Alshibani Z, Awad K, Alzayed A, Hassan H, Alsayiegh M. Acinetobacter baumannii Septicemia in a Recipient of an Allogeneic Hematopoietic Stem Cell Transplantation. Case Rep Transplant. 2012;2012:646195. doi: 10.1155/2012/646195. Epub 2012 Aug 07. PMID: 23259136; PMCID: PMC3504248.
Copy Download .nbib Format: NLM
Paramedics beliefs and attitudes towards pre-hospital thrombolysis.

International journal of applied & basic medical research

Alanazi AF, Alrashidi QS, Aljerian NA.
PMID: 24600571
Int J Appl Basic Med Res. 2014 Jan;4(1):11-5. doi: 10.4103/2229-516X.125672.

BACKGROUND: Myocardial infarction is the third leading cause of death in the developing countries. Thrombolysis as a reperfusion therapy is shown to have a great role in decreasing mortality. The efficacy of thrombolytic therapy lies in its ability to...

Cite
Alanazi AF, Alrashidi QS, Aljerian NA. Paramedics beliefs and attitudes towards pre-hospital thrombolysis. Int J Appl Basic Med Res. 2014;4(1):11-5doi: 10.4103/2229-516X.125672.
Alanazi, A. F., Alrashidi, Q. S., & Aljerian, N. A. (2014). Paramedics beliefs and attitudes towards pre-hospital thrombolysis. International journal of applied & basic medical research, 4(1), 11-5. https://doi.org/10.4103/2229-516X.125672
Alanazi, Abdullah Foraih, et al. "Paramedics beliefs and attitudes towards pre-hospital thrombolysis." International journal of applied & basic medical research vol. 4,1 (2014): 11-5. doi: https://doi.org/10.4103/2229-516X.125672
Alanazi AF, Alrashidi QS, Aljerian NA. Paramedics beliefs and attitudes towards pre-hospital thrombolysis. Int J Appl Basic Med Res. 2014 Jan;4(1):11-5. doi: 10.4103/2229-516X.125672. PMID: 24600571; PMCID: PMC3931206.
Copy Download .nbib Format: NLM
Efficacy of a single dose intravenous heparin in reducing sheath-thrombus formation during diagnostic angiography: A randomized controlled trial.

Journal of the Saudi Heart Association

Alamri HS, Almoghairi AM, Alghamdi AA, Almasood AS, Alotaiby MA, Kazim HM, Almutairi M, Alanazi A.
PMID: 23960661
J Saudi Heart Assoc. 2012 Jan;24(1):3-7. doi: 10.1016/j.jsha.2011.07.003. Epub 2011 Oct 21.

BACKGROUND: Femoral arterial sheath thrombosis and distal embolization are well-recognized complications of cardiac catheterization but the occlusion is extremely rare. Heparinized saline flushes are used during diagnostic coronary angiography to prevent thrombus formation within the sheath lumen. However, the...

Cite
Alamri HS, Almoghairi AM, Alghamdi AA, et al. Efficacy of a single dose intravenous heparin in reducing sheath-thrombus formation during diagnostic angiography: A randomized controlled trial. J Saudi Heart Assoc. 2011;24(1):3-7doi: 10.1016/j.jsha.2011.07.003.
Alamri, H. S., Almoghairi, A. M., Alghamdi, A. A., Almasood, A. S., Alotaiby, M. A., Kazim, H. M., Almutairi, M., & Alanazi, A. (2012). Efficacy of a single dose intravenous heparin in reducing sheath-thrombus formation during diagnostic angiography: A randomized controlled trial. Journal of the Saudi Heart Association, 24(1), 3-7. https://doi.org/10.1016/j.jsha.2011.07.003
Alamri, Hussein S, et al. "Efficacy of a single dose intravenous heparin in reducing sheath-thrombus formation during diagnostic angiography: A randomized controlled trial." Journal of the Saudi Heart Association vol. 24,1 (2012): 3-7. doi: https://doi.org/10.1016/j.jsha.2011.07.003
Alamri HS, Almoghairi AM, Alghamdi AA, Almasood AS, Alotaiby MA, Kazim HM, Almutairi M, Alanazi A. Efficacy of a single dose intravenous heparin in reducing sheath-thrombus formation during diagnostic angiography: A randomized controlled trial. J Saudi Heart Assoc. 2012 Jan;24(1):3-7. doi: 10.1016/j.jsha.2011.07.003. Epub 2011 Oct 21. PMID: 23960661; PMCID: PMC3727498.
Copy Download .nbib Format: NLM
2-Methyl-3-(2-methyl-phen-yl)-4-oxo-3,4-dihydro-quinazolin-8-yl 4-chloro-benzoate.

Acta crystallographica. Section E, Structure reports online

El-Azab AS, Abdel-Aziz AA, Alanazi AM, Ng SW, Tiekink ER.
PMID: 22807877
Acta Crystallogr Sect E Struct Rep Online. 2012 Jul 01;68:o2052-3. doi: 10.1107/S1600536812025147. Epub 2012 Jun 13.

In the title compound, C(23)H(17)ClN(2)O(3), the quinazoline fused-ring system, including the ring-bound carbonyl-O and methyl-C atoms, is close to being planar (r.m.s. deviation = 0.044 Å) and is essentially orthogonal to both the 2-tolyl ring [dihedral angle = 89.51...

Cite
El-Azab AS, Abdel-Aziz AA, Alanazi AM, et al. 2-Methyl-3-(2-methyl-phen-yl)-4-oxo-3,4-dihydro-quinazolin-8-yl 4-chloro-benzoate. Acta Crystallogr Sect E Struct Rep Online. 2012;68:o2052-3doi: 10.1107/S1600536812025147.
El-Azab, A. S., Abdel-Aziz, A. A., Alanazi, A. M., Ng, S. W., & Tiekink, E. R. (2012). 2-Methyl-3-(2-methyl-phen-yl)-4-oxo-3,4-dihydro-quinazolin-8-yl 4-chloro-benzoate. Acta crystallographica. Section E, Structure reports online, 68o2052-3. https://doi.org/10.1107/S1600536812025147
El-Azab, Adel S, et al. "2-Methyl-3-(2-methyl-phen-yl)-4-oxo-3,4-dihydro-quinazolin-8-yl 4-chloro-benzoate." Acta crystallographica. Section E, Structure reports online vol. 68 (2012): o2052-3. doi: https://doi.org/10.1107/S1600536812025147
El-Azab AS, Abdel-Aziz AA, Alanazi AM, Ng SW, Tiekink ER. 2-Methyl-3-(2-methyl-phen-yl)-4-oxo-3,4-dihydro-quinazolin-8-yl 4-chloro-benzoate. Acta Crystallogr Sect E Struct Rep Online. 2012 Jul 01;68:o2052-3. doi: 10.1107/S1600536812025147. Epub 2012 Jun 13. PMID: 22807877; PMCID: PMC3393320.
Copy Download .nbib Format: NLM
Oral squamous cell carcinoma among Yemenis: Onset in young age and presentation at advanced stage.

Journal of clinical and experimental dentistry

Halboub E, Al-Mohaya M, Abdulhuq M, Al-Mandili A, Al-Anazi Y.
PMID: 24558559
J Clin Exp Dent. 2012 Oct 01;4(4):e221-5. doi: 10.4317/jced.50824. eCollection 2012 Oct.

OBJECTIVES: Oral cancer represents a health burden worldwide. Up to 90% of oral cancer cases are squamous cell carcinomas (SCC). The data on oral SCC in Yemen are lacking. The objective of this study therefore was to describe and...

Cite
Halboub E, Al-Mohaya M, Abdulhuq M, et al. Oral squamous cell carcinoma among Yemenis: Onset in young age and presentation at advanced stage. J Clin Exp Dent. 2012;4(4):e221-5doi: 10.4317/jced.50824.
Halboub, E., Al-Mohaya, M., Abdulhuq, M., Al-Mandili, A., & Al-Anazi, Y. (2012). Oral squamous cell carcinoma among Yemenis: Onset in young age and presentation at advanced stage. Journal of clinical and experimental dentistry, 4(4), e221-5. https://doi.org/10.4317/jced.50824
Halboub, Esam, et al. "Oral squamous cell carcinoma among Yemenis: Onset in young age and presentation at advanced stage." Journal of clinical and experimental dentistry vol. 4,4 (2012): e221-5. doi: https://doi.org/10.4317/jced.50824
Halboub E, Al-Mohaya M, Abdulhuq M, Al-Mandili A, Al-Anazi Y. Oral squamous cell carcinoma among Yemenis: Onset in young age and presentation at advanced stage. J Clin Exp Dent. 2012 Oct 01;4(4):e221-5. doi: 10.4317/jced.50824. eCollection 2012 Oct. PMID: 24558559; PMCID: PMC3917628.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 476 entries